Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2014 | 09-2008 | 09-2007 | 09-2006 | 09-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,700 | 24,597 | 9,158 | 30,333 | 72,503 |
| Marketable Securities | N/A | N/A | 51,919 | 79,210 | 52,226 |
| Receivables | 65 | 1,752 | 639 | 46 | 149 |
| Other current assets | 0 | 1,424 | 1,524 | 2,575 | 347 |
| TOTAL | $3,827 | $27,773 | $63,240 | $112,165 | $125,225 |
| Non-Current Assets | |||||
| PPE Net | 14 | 5,301 | 6,045 | 3,593 | 2,518 |
| Intangibles | 361 | 0 | 0 | 0 | 0 |
| TOTAL | $375 | $5,301 | $6,045 | $3,593 | $2,518 |
| Total Assets | $4,202 | $41,070 | $78,075 | $125,028 | $130,716 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 587 | 0 | 0 | 0 | 0 |
| TOTAL | $587 | $16,885 | $18,521 | $36,983 | $13,013 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,640 | 0 | 0 | 0 | 0 |
| TOTAL | $1,640 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,228 | $135,161 | $139,367 | $157,049 | $113,768 |
| Shareholders' Equity | |||||
| Common Shares | 4,194 | N/A | N/A | N/A | N/A |
| Retained earnings | -5,949 | -444,828 | -408,157 | -345,369 | -187,976 |
| Other shareholders' equity | 893 | 350,737 | 346,866 | 313,347 | 204,923 |
| TOTAL | $1,974 | $-94,091 | $-61,292 | $-32,021 | $16,947 |
| Total Liabilities And Equity | $4,202 | $41,069 | $78,075 | $125,028 | $130,716 |